BioMimetic Pharmaceuticals, Inc.
330 Mallory Station, Suite A-1
Franklin
Tennessee
37067
United States
Tel: 615-844-1280
Fax: 615-844-1281
Website: http://www.biomimetics.com/
Email: DL@biomimetics.com
9 articles about BioMimetic Pharmaceuticals, Inc.
-
BioMimetic Pharmaceuticals, Inc. to Introduce Augmatrix™ Biocomposite Bone Graft Product Line at American Academy of Orthopaedic Surgeons
2/8/2012
-
BioMimetic Pharmaceuticals, Inc. to Present at the Jefferies and Co. Global Healthcare Conference
6/6/2011
-
BioMimetic Pharmaceuticals, Inc.'s Bone Product Trial Disappoints
10/14/2009
-
BioMimetic Pharmaceuticals, Inc. Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures
10/29/2008
-
BioMimetic Pharmaceuticals, Inc. Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1Bone Graft
6/7/2007
-
The Week In Review: Big Week For IPOs
2/12/2007
-
The Day In Review: SuperGen, Inc. Drug Disappoints
4/26/2006
-
BioMimetic Therapeutics Initiates Clinical Trials With Novel Bio-Active Drug-Device Combination Bone Graft In Two Orthopedic Indications
3/20/2006
-
BioMimetic Therapeutics Files For $50 Million IPO
2/10/2006